Additional files
More articles from Volume 6, Issue 2, 2023
Blockchain Technology Predictions 2024: Transformations in Healthcare, Patient Identity and Public Health
Problems with Medical Claims that Artificial Intelligence (AI) and Blockchain Can Fix
Accelerating the Worldwide Adoption of Blockchain Technology
Moving Beyond POCs and Pilots to Mainstream: Discovery and Lessons from Blockchain in Healthcare
Privacy-Conflict Resolution for Integrating Personal- and Electronic Health Records in Blockchain-Based Systems
Article views
Why Industry-Wide Standards Matter In Fulfilling the Intent of DSCSA
Abstract
Speakers discuss the importance of standardization in order to digitalize the U.S. pharmaceutical supply chain as motivated by the Drug Supply Chain Security Act (DSCSA). Key topics What is DSCSA? What does FDA’s Stabilization Period mean? Why do technology standards matter and how are they being implemented, i.e. interoperability through standards? Focus on standardization, due diligence in the context of DSCSA-regulated digitally managed pharma supply chain 2023 readiness in relation to stabilization period until 2024 Inspections will keep happening ATP is mandatory, authentication & authorization Data security
Keywords
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article metrics
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
